Clinical and pharmacogenetic influences on response to hydroxychloroquine in discoid lupus erythematosus: A retrospective cohort study

Journal of Investigative Dermatology

Volumn 131, Issue 10, 2011, Pages 1981-1986

  Wahie, Shyamal ^a   Daly, Ann K ^a   Cordell, Heather J ^a   Goodfield, Mark J ^b   Jones, Stephen K ^c   Lovell, Christopher R ^d   Carmichael, Andrew J ^e   Carr, Mary M ^f   Drummond, Angela ^g   Natarajan, Sivakumar ^h   Smith, Catherine H ⁱ   Reynolds, Nick J ^a,j   Meggitt, Simon J ^a,j  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b LEEDS GENERAL INFIRMARY   (United Kingdom)

^c CLATTERBRIDGE HOSPITAL   (United Kingdom)

^d ROYAL UNITED HOSPITAL   (United Kingdom)

^e JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

^f UNIVERSITY HOSPITAL OF NORTH DURHAM   (United Kingdom)

^g SOUTHERN GENERAL HOSPITAL   (United Kingdom)

^h SUNDERLAND ROYAL HOSPITAL   (United Kingdom)

ⁱ ST THOMAS HOSPITAL   (United Kingdom)

^j ROYAL VICTORIA INFIRMARY   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; HYDROXYCHLOROQUINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; DISCOID LUPUS ERYTHEMATOSUS; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG RESPONSE; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL SYMPTOM; GENETIC POLYMORPHISM; HEART PALPITATION; HUMAN; MAJOR CLINICAL STUDY; MALAISE; MALE; OBSERVATIONAL STUDY; PHARMACOGENETICS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SYSTEMIC DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 80052869325     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2011.167     Document Type: Article

References (26)

1. Bahadur N, Leathart JB, Mutch E et al. (2002) CYP2C8 polymorphisms in Caucasians and their relationship with paclitaxel 6 alpha-hydroxylase activity in human liver microsomes. Biochem Pharmacol 64: 1579-89 (Pubitemid 35333419)
2. Boeckler P, Cosnes A, Francès C et al. (2009) Association of cigarette smoking but not alcohol consumption with cutaneous lupus erythematosus. Arch Dermatol 145:1012-6
3. Costedoat-Chalumeau N, Amoura Z, Hulot JS et al. (2006) Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus. Arthritis Rheum 54:3284-90 (Pubitemid 44622099)
4. Daly AK, Steen VM, Fairbrother KS et al. (1996) CYP2D6 multiallelism. Methods Enzymol 272:199-210 (Pubitemid 26299883)
5. Gil JP, Gil Bergluand E (2007) CYP2C8 and antimalarial drug efficacy. Pharmacogenomics 8:187-98
6. Ghaussy WO, Sibbitt WL, Bankhurst AD et al. (2003) Cigarette smoking and disease activity in systemic lupus erythematosus. J Rheumatol 30:1215-21 (Pubitemid 36666343)
7. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725
8. Jessop S, Whitelaw DA, Delamere FM (2009) Drugs for discoid lupus erythematosus. Cochrane Database Syst Rev 7:CD002954
9. Jewell JD, McCauliffe DP (2000) Patients with cutaneous lupus erythematosus who smoke are less responsive to antimalarial treatment. J Am Acad Dermatol 42:983-7
10. Kim KA, Park JY, Lee SJ et al. (2003) Cytochrome P450 2C8 and CYP 3A4/5 are involved in chloroquine metabolism in human liver microsomes. Arch Pharm Res 26:631-7
11. Kuhn A, Ruland V, Bonsmann G (2010) Cutaneous lupus erythematosus: update of therapeutic options part I. J Am Acad Dermatol; e-pub ahead of print 25 August 2010
12. Kyriakis KP, Michailides C, Palamara I et al. (2007) Lifetime prevalence distribution of chronic discoid lupus erythematosus. J Eur Acad Derm Venerol 21:1105-47
13. Lardet D, Martin S, Truchet F (2004) Effect of smoking on the effectiveness of antimalarial drugs for cutaneous lesions of patients with lupus: assessment in a prospective study. Rev Med Interne 25:786-91 (Pubitemid 40292251)
14. Moghadam-Kia S, Chilek K, Gaines E et al. (2009) Cross-sectional analysis of a collaborative web-based database for lupus erythematosus-associated skin lesions: prospective enrollment of 114 patients. Arch Dermatol 145:255-60
15. Miot HA, Bartoli Miot LD, Haddad GR (2005) Association between discoid lupus erythematosus and smoking. Dermatology 211:118-22
16. Munster T, Gibbs JP, Shen D et al. (2002) Hydroxychloroquine concentration-response relationships in patients with rheumatoid arthritis. Arthritis Rheum 46:1460-9 (Pubitemid 34620191)
17. Niemi M, Leathart JB, Neuvorten A et al. (2003) Polymorphism in CYP2C8 is associated with reduced plasma concentrations of repaglinide. Clin Pharmacol Ther 74:380-7 (Pubitemid 37222859)
18. Parikh S, Ouedraogo JB, Goldstein JA et al. (2007) Amodiaquine metabolism is impaired by common polymorphisms in CYP2C8: implications for malaria treatment in Africa. Clin Pharmacol Ther 82:197-203 (Pubitemid 47075331)
19. Projean D, Baune B, Farinotti R et al. (2003) In vitro metabolism of chloroquine: identification of CYP 2C8, CYP 3A4, and CYP2D6 as the main isoforms catalyzing N-desethylchloroquine formation. Drug Met Dispos 31:748-54 (Pubitemid 36617663)
20. Rahman P, Gladman DD, Urowitz MB (1998) Smoking interferes with efficacy of antimalarial therapy in cutaneous lupus. J Rheumatol 25:1716-9 (Pubitemid 28439264)
21. Tebbe B, Orfanos CE (1997) Epidemiology and socioeconomic impact of skin disease in lupus erythematosus. Lupus 6:96-104 (Pubitemid 27102036)
22. Tett SE, Cutler DJ, Beck C et al. (2000) Concentration-effect relationship of hydroxychloroquine in patients with rheumatoid arthritis-a prospective, dose ranging study. J Rheumatol 27:1656-60 (Pubitemid 30462807)
23. Tett SE, Day RO, Cutler DJ (1993) Concentration-effect relationship of hydroxychloroquine in rheumatoid arthritis-a cross-sectional study. J Rheumatol 20:1874-9 (Pubitemid 24031590)
24. Vera-Recabarren MA, García-Carrasco M, Ramos-Casals M et al. (2010) Comparative analysis of subacute cutaneous lupus erythematosus and chronic cutaneous lupus erythematosus: clinical and immunological study of 270 patients. Br J Dermatol 162:91-101
25. Wahie S, McColl E, Reynolds NJ et al. (2010) Measuring disease activity and damage in discoid lupus erythematosus. Br J Dermatol 162:1030-7
26. Walling HW, Sontheimer RD (2009) Cutaneous lupus erythematosus: issues in diagnosis and treatment. Am J Clin Dermatol 10:365-81